# CER1

## Overview
The CER1 gene encodes the protein cerberus 1, a member of the DAN family of bone morphogenetic protein (BMP) antagonists. Cerberus 1 is a secreted protein that plays a critical role in embryonic development by modulating signaling pathways, particularly those involving the transforming growth factor-β (TGF-β) family. It functions as an extracellular antagonist, inhibiting specific ligands such as Nodal, Activin B, BMP-6, and BMP-7, thereby influencing processes like head induction, heart development, and left-right asymmetry during embryogenesis (Aykul2016New). Additionally, cerberus 1 is implicated in bone health, with genetic variations in CER1 linked to bone mineral density and the risk of osteoporotic fractures, particularly in postmenopausal women (Koromila2012Novel; Koromila2013CER1gene). The protein's ability to act as a ligand trap is essential for maintaining proper bone remodeling and development (Koromila2013CER1gene).

## Function
The CER1 gene encodes the Cerberus protein, a member of the DAN family of BMP antagonists, which plays a significant role in regulating signaling pathways crucial for embryonic development and bone health. Cerberus functions as a secreted antagonist of the transforming growth factor-β (TGF-β) family, specifically inhibiting ligands such as Nodal, Activin B, BMP-6, and BMP-7, but not BMP-2 or Activin A (Aykul2016New). This inhibition is achieved through its ability to prevent ligand binding to type II receptors, thereby modulating cellular signaling pathways (Aykul2016New).

In healthy human cells, Cerberus is involved in processes such as head induction, heart development, and the regulation of left-right asymmetry during embryogenesis (Aykul2016New). It also plays a role in bone mineral density regulation, with variations in the CER1 gene being associated with bone health and the risk of osteoporotic fractures in postmenopausal women (Koromila2012Novel; Koromila2013CER1gene). The protein's activity is primarily extracellular, where it acts as a ligand trap to inhibit BMP functions, crucial for maintaining proper bone remodeling and development (Koromila2013CER1gene).

## Clinical Significance
Mutations and variations in the CER1 gene have been associated with several clinical conditions, particularly in postmenopausal women. Research has shown that specific single nucleotide polymorphisms (SNPs) in the CER1 gene are significantly linked to low bone mineral density (BMD) and an increased risk of osteoporotic fractures. For instance, the c.531A[G SNP is associated with a higher incidence of vertebral fractures, while the c.507?506G[T polymorphism is independently linked to hip fractures (Koromila2012Novel). These genetic variations in CER1 may serve as predictive markers for osteoporosis and related fractures, highlighting their potential role in bone health (Koromila2013CER1gene).

The CER1 gene is involved in the TGFbeta signaling pathway and acts as an antagonist to bone morphogenetic proteins (BMPs), which are crucial for bone development and remodeling. Alterations in CER1 expression or its interactions can impact bone metabolism, as evidenced by associations with bone markers such as parathyroid hormone, calcitonin, osteocalcin, and insulin-like growth factor 1 (Koromila2013CER1gene). These findings underscore the clinical significance of CER1 in the context of osteoporosis and bone fragility.


## References


[1. (Koromila2012Novel) Theodora Koromila, Zoe Dailiana, Stavroula Samara, Chris Chassanidis, Chara Tzavara, George P. Patrinos, Vassiliki Aleporou-Marinou, and Panagoula Kollia. Novel sequence variations in the cer1 gene are strongly associated with low bone mineral density and risk of osteoporotic fracture in postmenopausal women. Calcified Tissue International, 91(1):15–23, April 2012. URL: http://dx.doi.org/10.1007/s00223-012-9602-9, doi:10.1007/s00223-012-9602-9. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00223-012-9602-9)

[2. (Aykul2016New) Senem Aykul and Erik Martinez-Hackert. New ligand binding function of human cerberus and role of proteolytic processing in regulating ligand–receptor interactions and antagonist activity. Journal of Molecular Biology, 428(3):590–602, February 2016. URL: http://dx.doi.org/10.1016/j.jmb.2016.01.011, doi:10.1016/j.jmb.2016.01.011. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2016.01.011)

[3. (Koromila2013CER1gene) Theodora Koromila, Panagiotis Georgoulias, Zoe Dailiana, Evangelia E Ntzani, Stavroula Samara, Chris Chassanidis, Vassiliki Aleporou-Marinou, and Panagoula Kollia. Cer1gene variations associated with bone mineral density, bone markers, and early menopause in postmenopausal women. Human Genomics, October 2013. URL: http://dx.doi.org/10.1186/1479-7364-7-21, doi:10.1186/1479-7364-7-21. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1479-7364-7-21)